Tag Archive for: SpliceBio

SpliceBio
Gene therapy

SpliceBio lauches Phase I/II study on dual-AAV-based therapy for Stargardt Disease

Spanish SpliceBio has dosed the first patient with SB-007, the first dual AAV gene therapy in clinical development for Stargardt disease

Read more
Collaboration

SpliceBio has made up a US $216m alliance with Spark Therapeutics

SpliceBio has licenced its intein technlogy to Roche’s gene therapy subsidiary Spark Therapeutics to develop a gene therapy targeting an undisclosed inherited retinal disease.

Read more